Singapore-Based A SPAC II Acquisition Prices US$185 Million IPO

Special purpose acquisition company A SPAC II Acquisition Corp. (Nasdaq: ASCBU) started trading on the Nasdaq Capital Market on Tuesday. The firm aims to raise US$185.0 million in its initial public offering.

The offering consisted of 18.5 million company units at US$10.00 per unit. Each unit contains one Class A common share, one-half of a redeemable warrant, and one-tenth of a right. Each whole warrant is exercisable for one common share at US$11.50 per share while each whole right equates to one common share upon business combination. The shares, warrants, and rights, once trading separately, will be trading under “ASCB”, “ASCBW”, and “ASCBR”, respectively.

Maxim Group acts as the sole bookrunner for the said offering. The underwriters were granted a 45-day overallotment option to purchase additional 2.8 million units at the same IPO price.

Antimony Resources — sponsored Sponsored · Antimony Resources

The Singapore-based blank check firm intends to focus on completing a business combination in Proptech and Fintech, with particular preference to companies employing ESG principles.

Its predecessor A SPAC I Acquisition Corp. (Nasdaq: ASCAU) launched its US$60-million initial public offering in February 2022.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is in a New Price Regime, and the Market Isn’t Used to It | Keith Neumeyer – First Majestic

Agnico Eagle Just Made a Massive Gold Land Grab

A Copper-Gold Deposit Caught the White House’s Attention | Rob McLeod – Cambria Gold

Recommended

Mercado Drills 256 g/t Silver Over 6.5 Metres In First Drill Hole of Inaugural Program

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Trending

Related News

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

SPAC Healthcare Capital Secures Shareholder Approval Of US$1 Billion SPAC Merger

Special purpose acquisition company Healthcare Capital Corp. (Nasdaq: HCCC) announced today that it has secured...

Tuesday, February 22, 2022, 02:21:00 PM

Eye Care Firm Bausch + Lomb Seeks To Raise $630 Million In NYSE, TSX IPOs

Bausch Health Companies (NYSE/TSX: BHC) subsidiary, eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO)...

Friday, May 6, 2022, 02:24:00 PM

Richard Branson’s Virgin Orbit Closes SPAC Reverse Merger, Misses Fundraising Target

Richard Branson’s aerospace firm Virgin Orbit took its Nasdaq flight on Thursday. The firm’s parent...

Friday, December 31, 2021, 02:40:00 PM

Electric Vehicle Maker Iconiq Motors To Be Taken Public In A US$2.5 Billion SPAC Merger

Electric vehicle company Iconiq Motors entered into a definitive business combination agreement with special purpose...

Monday, April 18, 2022, 02:24:00 PM